The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
出版年份 2021 全文链接
标题
The role of distinct BRD4 isoforms and their contribution to high-grade serous ovarian carcinoma pathogenesis
作者
关键词
-
出版物
Molecular Cancer
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-11-10
DOI
10.1186/s12943-021-01424-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical perspectives of BET inhibition in ovarian cancer
- (2021) Angeliki Andrikopoulou et al. CELLULAR ONCOLOGY
- Bromodomain-containing protein 4 silencing by microRNA-765 produces anti-ovarian cancer cell activity
- (2021) Yong-Jun Ji et al. Aging-US
- Targeting Nrf2 may reverse the drug resistance in ovarian cancer
- (2021) Danjie Li et al. Cancer Cell International
- The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models
- (2021) Tiziana Servidei et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Metalloproteinases in Ovarian Cancer
- (2021) Preston Carey et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- PCAF ‐mediated acetylation of ISX recruits BRD 4 to promote epithelial‐mesenchymal transition
- (2020) Li‐Ting Wang et al. EMBO REPORTS
- JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer
- (2020) Tina Bagratuni et al. EUROPEAN JOURNAL OF CANCER
- Evolving population-based statistics for rare epithelial ovarian cancers
- (2020) Koji Matsuo et al. GYNECOLOGIC ONCOLOGY
- CCNE1 and BRD4 co-amplification in high-grade serous ovarian cancer is associated with poor clinical outcomes
- (2020) Shariska Petersen et al. GYNECOLOGIC ONCOLOGY
- Targeting DNA Repair in Ovarian Cancer Treatment Resistance
- (2020) M.W. Wong-Brown et al. CLINICAL ONCOLOGY
- Opposing Functions of BRD4 Isoforms in Breast Cancer
- (2020) Shwu-Yuan Wu et al. MOLECULAR CELL
- Roles of the BRD4 short isoform in phase separation and active gene transcription
- (2020) Xinye Han et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MYC protein stability is negatively regulated by BRD4
- (2020) Ballachanda N. Devaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of the key genes associated with chemotherapy sensitivity in ovarian cancer patients
- (2020) Hui Zheng et al. Cancer Medicine
- The Long and the Short of BRD4: Two Tales in Breast Cancer
- (2020) Sicong Zhang et al. MOLECULAR CELL
- First-in-human Phase 1 open label study of the BET inhibitor ODM-207 in patients with selected solid tumours
- (2020) Malaka Ameratunga et al. BRITISH JOURNAL OF CANCER
- THERAPY OF ENDOCRINE DISEASE: Endocrine-metabolic effects of treatment with multikinase inhibitors
- (2020) Poupak Fallahi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Homologous recombination deficiency real-time clinical assays, ready or not?
- (2020) Katherine Fuh et al. GYNECOLOGIC ONCOLOGY
- Reprogramming of nucleotide metabolism mediates synergy between epigenetic therapy and MAP Kinase inhibition
- (2020) Tatiana Shorstova et al. MOLECULAR CANCER THERAPEUTICS
- The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma
- (2020) Tyler Maser et al. Cancer Medicine
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibition of BRD4 suppresses the malignancy of breast cancer cells via regulation of Snail
- (2019) Linlin Lu et al. CELL DEATH AND DIFFERENTIATION
- Intrinsic Resistance to MEK Inhibition Through BET Protein Mediated Kinome Reprogramming in NF1-deficient Ovarian Cancer
- (2019) Alison M Kurimchak et al. MOLECULAR CANCER RESEARCH
- Development of 2 Bromodomain and Extraterminal Inhibitors With Distinct Pharmacokinetic and Pharmacodynamic Profiles for the Treatment of Advanced Malignancies
- (2019) Gerald S. Falchook et al. CLINICAL CANCER RESEARCH
- First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid Tumors
- (2019) Sarina A. Piha-Paul et al. CLINICAL CANCER RESEARCH
- ALDH1A1 contributes to PARP inhibitor resistance via enhancing DNA repair in BRCA2-/- ovarian cancer cells
- (2019) Lu Liu et al. MOLECULAR CANCER THERAPEUTICS
- Akt/mTOR-Mediated Autophagy Confers Resistance To BET Inhibitor JQ1 In Ovarian Cancer
- (2019) Wenqing Luan et al. OncoTargets and Therapy
- Molecular mechanisms of epithelial to mesenchymal transition in tumor metastasis
- (2019) Artur Nieszporek et al. ACTA BIOCHIMICA POLONICA
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- SUSD2 promotes cancer metastasis and confers cisplatin resistance in high grade serous ovarian cancer
- (2018) Ying Xu et al. EXPERIMENTAL CELL RESEARCH
- The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer
- (2018) Andrew J. Wilson et al. GYNECOLOGIC ONCOLOGY
- Phase Ib Trial With Birabresib, a Small-Molecule Inhibitor of Bromodomain and Extraterminal Proteins, in Patients With Selected Advanced Solid Tumors
- (2018) Jeremy Lewin et al. JOURNAL OF CLINICAL ONCOLOGY
- BET Proteins Exhibit Transcriptional and Functional Opposition in the Epithelial-to-Mesenchymal Transition
- (2018) Guillaume P. Andrieu et al. MOLECULAR CANCER RESEARCH
- BRD4 facilitates replication stress-induced DNA damage response
- (2018) Jingwen Zhang et al. ONCOGENE
- Coactivator condensation at super-enhancers links phase separation and gene control
- (2018) Benjamin R. Sabari et al. SCIENCE
- Chromatin conformation regulates the coordination between DNA replication and transcription
- (2018) Ricardo Almeida et al. Nature Communications
- DNA damage repair in ovarian cancer: unlocking the heterogeneity
- (2018) Mary Ellen Gee et al. Journal of Ovarian Research
- Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
- (2018) Karin Bauer et al. Oncotarget
- BRD4 Promotes DNA Repair and Mediates the Formation of TMPRSS2-ERG Gene Rearrangements in Prostate Cancer
- (2018) Xiangyi Li et al. Cell Reports
- Inhibition of bromodomain and extraterminal domain reduces growth and invasive characteristics of chemoresistant ovarian carcinoma cells
- (2018) Majid Momeny et al. ANTI-CANCER DRUGS
- The BET bromodomain inhibitor i-BET151 impairs ovarian cancer metastasis and improves antitumor immunity
- (2018) Ai Liu et al. CELL AND TISSUE RESEARCH
- BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors
- (2018) Garrett W. Rhyasen et al. PLoS One
- Targeting Brd4 for cancer therapy: inhibitors and degraders
- (2018) Yingchao Duan et al. MedChemComm
- BRD4 and Cancer: going beyond transcriptional regulation
- (2018) Benedetta Donati et al. Molecular Cancer
- Predicting novel therapies and targets: Regulation of Notch3 by the bromodomain protein BRD4
- (2018) Alejandro Villar-Prados et al. MOLECULAR CANCER THERAPEUTICS
- Expression Patterns of Nrf2 and Keap1 in Ovarian Cancer Cells and their Prognostic Role in Disease Recurrence and Patient Survival
- (2017) Hye-yon Cho et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- BET Bromodomain Inhibition Synergizes with PARP Inhibitor in Epithelial Ovarian Cancer
- (2017) Sergey Karakashev et al. Cell Reports
- Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer
- (2017) Bo Zhou et al. Frontiers of Medicine
- Targeting chromatin defects in selected solid tumors based on oncogene addiction, synthetic lethality and epigenetic antagonism
- (2016) D. Morel et al. ANNALS OF ONCOLOGY
- BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer
- (2016) Yuhki Yokoyama et al. CANCER RESEARCH
- Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib
- (2016) Aiste McCormick et al. CLINICAL CANCER RESEARCH
- BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
- (2016) Ballachanda N Devaiah et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets
- (2016) Shuhui Chen et al. Oncology Letters
- BRD4 is a histone acetyltransferase that evicts nucleosomes from chromatin
- (2016) Ballachanda N Devaiah et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- BET Bromodomain Inhibition as a Therapeutic Strategy in Ovarian Cancer by Downregulating FoxM1
- (2016) Zhenfeng Zhang et al. Theranostics
- Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
- (2016) Alison M. Kurimchak et al. Cell Reports
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Histo-genomic stratification reveals the frequent amplification/overexpression ofCCNE1andBRD4genes in non-BRCAness high grade ovarian carcinoma
- (2015) Oumou Goundiam et al. INTERNATIONAL JOURNAL OF CANCER
- Targeting the DNA Damage Response in Cancer
- (2015) Mark J. O’Connor MOLECULAR CELL
- JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer
- (2015) Haifeng Qiu et al. Oncotarget
- Concomitant BET and MAPK blockade for effective treatment of ovarian cancer
- (2015) Ying Jing et al. Oncotarget
- Abstract LB-40: Induciblein vivosilencing of Brd4 identifies potential toxicities of sustained BET protein inhibition
- (2015) Jessica Bolden et al. CANCER RESEARCH
- The molecular genetics of hereditary and sporadic ovarian cancer: implications for the future
- (2014) M. Al Bakir et al. BRITISH MEDICAL BULLETIN
- Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread
- (2014) Sunila Pradeep et al. CANCER CELL
- Notch3 Pathway Alterations in Ovarian Cancer
- (2014) W. Hu et al. CANCER RESEARCH
- Histone Cross-talk Connects Protein Phosphatase 1α (PP1α) and Histone Deacetylase (HDAC) Pathways to Regulate the Functional Transition of Bromodomain-containing 4 (BRD4) for Inducible Gene Expression
- (2014) Xiangming Hu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Bromodomain and Extraterminal Proteins Suppress NF-E2-Related Factor 2-Mediated Antioxidant Gene Expression
- (2014) C. Michaeloudes et al. JOURNAL OF IMMUNOLOGY
- Chromatin Reader Brd4 Functions in Ig Class Switching as a Repair Complex Adaptor of Nonhomologous End-Joining
- (2014) Andre Stanlie et al. MOLECULAR CELL
- ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling
- (2014) Erhong Meng et al. PLoS One
- An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma
- (2014) Maria Giuseppina Baratta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response
- (2014) M Hussong et al. Cell Death & Disease
- Transformation Resistance in a Premature Aging Disorder Identifies a Tumor-Protective Function of BRD4
- (2014) Patricia Fernandez et al. Cell Reports
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer
- (2013) Philipp Tropberger et al. CELL
- Notch3 induces epithelial–mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells
- (2013) Nidhi Gupta et al. GYNECOLOGIC ONCOLOGY
- A distinctive ovarian cancer molecular subgroup characterized by poor prognosis and somatic focal copy number amplifications at chromosome 19
- (2013) Chang Ohk Sung et al. GYNECOLOGIC ONCOLOGY
- Roles of Chk1 in cell biology and cancer therapy
- (2013) Youwei Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
- (2013) Chiara Gorrini et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The bromodomain protein Brd4 insulates chromatin from DNA damage signalling
- (2013) Scott R. Floyd et al. NATURE
- Emerging landscape of oncogenic signatures across human cancers
- (2013) Giovanni Ciriello et al. NATURE GENETICS
- Brd4 Shields Chromatin from ATM Kinase Signaling Storms
- (2013) S. Choi et al. Science Signaling
- Bromodomain Protein Brd4 Associated with Acetylated Chromatin Is Important for Maintenance of Higher-order Chromatin Structure
- (2012) Ranran Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
- (2012) B. N. Devaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deletion of the Proline-Rich Region of the Murine Metastasis Susceptibility Gene Brd4 Promotes Epithelial-to-Mesenchymal Transition- and Stem Cell-Like Conversion
- (2011) J. Alsarraj et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation
- (2011) Rui Zhao et al. NATURE CELL BIOLOGY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Pol II waiting in the starting gates: Regulating the transition from transcription initiation into productive elongation
- (2010) Sergei Nechaev et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- An Activated ErbB3/NRG1 Autocrine Loop Supports In Vivo Proliferation in Ovarian Cancer Cells
- (2010) Qing Sheng et al. CANCER CELL
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Genomic instability — an evolving hallmark of cancer
- (2010) Simona Negrini et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
- (2009) Anup Dey et al. MOLECULAR BIOLOGY OF THE CELL
- Bromodomain 4 activation predicts breast cancer survival
- (2008) N. P. S. Crawford et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation